AllianceBernstein’s Niagen Bioscience NAGE Stock Holding History

AllianceBernstein’s Portfolio NAGE Stock Details NAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$239K	Sell	54,150 -268,811	-83%	-$1.09M	﹤0.01%	3090
2026 Q1	$2.05M	Buy	322,961 +64,341	+25%	+$347K	﹤0.01%	1989
2025 Q4	$1.64M	Buy	258,620 +109,500	+73%	+$762K	﹤0.01%	2108
2025 Q3	$1.39M	Buy	149,120 +98,770	+196%	+$997K	﹤0.01%	2194
2025 Q2	$726K	Buy	50,350 +40,300	+401%	+$398K	﹤0.01%	2457
2025 Q1	$69.3K	Hold	10,050	–	–	﹤0.01%	3101
2024 Q4	$53.3K	Hold	10,050	–	–	﹤0.01%	3182
2024 Q3	$36.7K	Hold	10,050	–	–	﹤0.01%	3204
2024 Q2	$27.4K	Buy	+10,050	New	+$33.6K	﹤0.01%	3216
2022 Q2	–	Sell	-24,100	Closed	-$59K	–	3405
2022 Q1	$59K	Sell	24,100 -5,200	-18%	-$14.2K	﹤0.01%	3166
2021 Q4	$110K	Hold	29,300	–	–	﹤0.01%	3182
2021 Q3	$184K	Hold	29,300	–	–	﹤0.01%	3105
2021 Q2	$289K	Buy	29,300 +14,800	+102%	+$129K	﹤0.01%	3021
2021 Q1	$135K	Sell	14,500 -29,700	-67%	-$235K	﹤0.01%	3124
2020 Q4	$212K	Hold	44,200	–	–	﹤0.01%	2972
2020 Q3	$177K	Sell	44,200 -2,700	-6%	-$13K	﹤0.01%	2980
2020 Q2	$215K	Buy	46,900 +26,300	+128%	+$118K	﹤0.01%	2989
2020 Q1	$67K	Buy	20,600 +9,900	+93%	+$38K	﹤0.01%	3023
2019 Q4	$46K	Hold	10,700	–	–	﹤0.01%	3097
2019 Q3	$42K	Buy	+10,700	New	+$45.6K	﹤0.01%	3132

Other funds holding NAGE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TCM

Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AllianceBernstein's NAGE Position: Q2 2026 in Review

AllianceBernstein reduced its Niagen Bioscience (NAGE) stake by 83% in Q2 2026, selling an estimated $1.09M and leaving 54,150 shares worth $239K. The position accounts for ﹤0.01% of the portfolio, ranked #3090.

AllianceBernstein first reported a position in NAGE in Q3 2019 and has held it in 20 quarters since. The position peaked at $2.05M in Q1 2026. 140 funds tracked by Wall St. Rank hold NAGE as of Q2 2026.

AllianceBernstein held 54,150 shares of Niagen Bioscience worth $239K as of Q2 2026.
AllianceBernstein sold 268,811 Niagen Bioscience shares in Q2 2026, an estimated $1.09M.
Niagen Bioscience made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #3090 holding.
AllianceBernstein first reported a position in Niagen Bioscience in Q3 2019 and has held it in 20 quarters since.
AllianceBernstein's Niagen Bioscience position peaked at $2.05M in Q1 2026.
140 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.